← 產業報告目錄
Next-Generation Contraceptives Market Size, Share & Trends Analysis Distribution by Gender (Male, Female), End User (Hospital Pharmacies, Retail Pharmacies, Online Channels), Offering (Drugs, Devices), and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-23頁數 180報告編號 INSIGHTACE-34acc1a8d1
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2024 to 2031 projection horizon, the worldwide Next-Generation Contraceptives Market is projected to register a CAGR of 8.2%.
Next-Generation Contraceptives covers reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next-Generation Contraceptives Market Snapshot
Chapter 4. Global Next-Generation Contraceptives Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Gender Estimates & Trend Analysis
5.1. by Gender & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Gender:
5.2.1. Male
5.2.2. Female
Chapter 6. Market Segmentation 2: by End User Estimates & Trend Analysis
6.1. by End User & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Channels
6.2.4. Others
Chapter 7. Market Segmentation 3: by Offering Estimates & Trend Analysis
7.1. by Offering & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Offering:
7.2.1. Drugs
7.2.2. Devices
Chapter 8. Next-Generation Contraceptives Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.1.2. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.1.3. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.1.4. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.2.2. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.2.3. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.2.4. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.3.2. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.3.3. Asia-Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.3.4. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.4.2. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.4.3. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.4.4. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031
8.5.2. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031
8.5.3. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031
8.5.4. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie
9.2.2. Bayer Corporation
9.2.3. Cooper Surgical, Inc.
9.2.4. Church & Dwight Co, Inc.
9.2.5. Merck & Co Inc.
9.2.6. Pfizer
9.2.7. Reckitt Benckiser Group Plc
9.2.8. Teva Pharmaceuticals Industries Ltd.
9.2.9. The Female Health Company/Veru Inc.
9.2.10. Afaxys, Inc
9.2.11. Aditxt
9.2.12. Daré Bioscience, Inc
9.2.13. TherapeuticsMD, Inc
9.2.14. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們